Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2015 /
NCRI 2015 highlights

1st - 4th Nov 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.11.15
Views: 1646

Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK

Prof Swanton talks to ecancertv at NCRI 2015 about what he regards as the highlights of the conference.

In particular, he comments on the work being done to improve targeted approaches and find better drug combinations. It is important, he says, to predict resistance mechanisms and block them to improve progression-free survival (PFS) outcomes. We need to battle the evolution of cancer and grasp it head on, he says.

He notes the important work looking at the problem of late diagnosis, arguing that investing in early diagnosis measures (such as earlier referral by GPs following 'red flag' symptoms) is an "extremely cost-effective approach" when compared with the amount of money required for palliative care.

He also touches upon other developments being made in CAR T-cells and immune checkpoint blockades.





Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation